The Collaborative Biobank (CoBi): Donor and recipient samples & data to facilitate future research on hematopoietic cell transplantation

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Claudia Spielau - , DKMS Clinical Trials Unit (Author)
  • Carolin Bunzel - , DKMS Clinical Trials Unit (Author)
  • Stefan Abert - , DKMS Clinical Trials Unit (Author)
  • Henning Baldauf - , DKMS Clinical Trials Unit (Author)
  • Alexander H Schmidt - , DKMS Clinical Trials Unit (Author)
  • Johannes Schetelig - , Department of Internal Medicine I, DKMS Clinical Trials Unit (Author)

Abstract

Biobanking provides benefit for future generations by facilitating medical research and subsequent translation and application of research findings. Long-term storage and research involving biological material and associated data necessitate the proper implementation of ethical and legal standards. A key principle includes recognizing informed consent as a crucial element for legitimizing the collection of biological material and data. Furthermore, any collected material and data must be employed exclusively for the research framework that aligns with the explicit consent provided by the participants. Last but not least, data privacy and security are essential in biobanking. This review elucidates chances and limitations of biobanking in the field of allogeneic hematopoietic cell transplantation. We discuss the practical implementation of the requirements, illustrated by the Collaborative Biobank, a collaborative research platform for research in blood cancer.

Details

Original languageEnglish
Article number101551
Number of pages8
JournalBest practice & research. Clinical haematology
Volume37
Issue number2
Publication statusPublished - Jun 2024
Peer-reviewedYes

External IDs

Scopus 85190138273

Keywords

Sustainable Development Goals

Keywords

  • Allografts, Biological Specimen Banks, Hematopoietic Stem Cell Transplantation, Humans, Informed Consent, Tissue Donors